| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |